163 related articles for article (PubMed ID: 12562696)
1. Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species.
Kontoyiannis DP; Lewis RE; Osherov N; Albert ND; May GS
J Antimicrob Chemother; 2003 Feb; 51(2):313-6. PubMed ID: 12562696
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans.
Del Poeta M; Cruz MC; Cardenas ME; Perfect JR; Heitman J
Antimicrob Agents Chemother; 2000 Mar; 44(3):739-46. PubMed ID: 10681348
[TBL] [Abstract][Full Text] [Related]
3. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus.
Steinbach WJ; Schell WA; Blankenship JR; Onyewu C; Heitman J; Perfect JR
Antimicrob Agents Chemother; 2004 May; 48(5):1664-9. PubMed ID: 15105118
[TBL] [Abstract][Full Text] [Related]
4. In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.
Steinbach WJ; Singh N; Miller JL; Benjamin DK; Schell WA; Heitman J; Perfect JR
Antimicrob Agents Chemother; 2004 Dec; 48(12):4922-5. PubMed ID: 15561883
[TBL] [Abstract][Full Text] [Related]
5. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.
Arikan S; Lozano-Chiu M; Paetznick V; Rex JH
Antimicrob Agents Chemother; 2002 Jan; 46(1):245-7. PubMed ID: 11751145
[TBL] [Abstract][Full Text] [Related]
6. In vitro interaction of caspofungin and immunosuppressives against agents of mucormycosis.
Thakur M; Revankar SG
J Antimicrob Chemother; 2011 Oct; 66(10):2312-4. PubMed ID: 21795260
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus.
Steinbach WJ; Cramer RA; Perfect BZ; Henn C; Nielsen K; Heitman J; Perfect JR
Antimicrob Agents Chemother; 2007 Aug; 51(8):2979-81. PubMed ID: 17502415
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates.
Arikan S; Lozano-Chiu M; Paetznick V; Rex JH
Antimicrob Agents Chemother; 2001 Jan; 45(1):327-30. PubMed ID: 11120990
[TBL] [Abstract][Full Text] [Related]
9. In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points.
Shalit I; Shadkchan Y; Samra Z; Osherov N
Antimicrob Agents Chemother; 2003 Apr; 47(4):1416-8. PubMed ID: 12654681
[TBL] [Abstract][Full Text] [Related]
10. In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
Perea S; Gonzalez G; Fothergill AW; Kirkpatrick WR; Rinaldi MG; Patterson TF
Antimicrob Agents Chemother; 2002 Sep; 46(9):3039-41. PubMed ID: 12183266
[TBL] [Abstract][Full Text] [Related]
11. Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans.
Arndt C; Cruz MC; Cardenas ME; Heitman J
Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():1989-2000. PubMed ID: 10463165
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains.
Lamoth F; Juvvadi PR; Gehrke C; Steinbach WJ
Antimicrob Agents Chemother; 2013 Feb; 57(2):1035-9. PubMed ID: 23165466
[TBL] [Abstract][Full Text] [Related]
13.
Lee Y; Lee KT; Lee SJ; Beom JY; Hwangbo A; Jung JA; Song MC; Yoo YJ; Kang SH; Averette AF; Heitman J; Yoon YJ; Cheong E; Bahn YS
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30181374
[TBL] [Abstract][Full Text] [Related]
14. Sequential exposure of Aspergillus fumigatus to itraconazole and caspofungin: evidence of enhanced in vitro activity.
Kontoyiannis DP; Lewis RE; Lionakis MS; Albert ND; May GS; Raad II
Diagn Microbiol Infect Dis; 2003 Oct; 47(2):415-9. PubMed ID: 14522515
[TBL] [Abstract][Full Text] [Related]
15. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
Peter J; Armstrong D; Lyman CA; Walsh TJ
J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae.
Osherov N; May GS; Albert ND; Kontoyiannis DP
Antimicrob Agents Chemother; 2002 Aug; 46(8):2462-9. PubMed ID: 12121919
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991).
Espinel-Ingroff A
J Clin Microbiol; 2003 Jan; 41(1):403-9. PubMed ID: 12517880
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus.
Falloon K; Juvvadi PR; Richards AD; Vargas-Muñiz JM; Renshaw H; Steinbach WJ
PLoS One; 2015; 10(9):e0137869. PubMed ID: 26366742
[TBL] [Abstract][Full Text] [Related]
19. Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.
O'Shaughnessy EM; Meletiadis J; Stergiopoulou T; Demchok JP; Walsh TJ
J Antimicrob Chemother; 2006 Dec; 58(6):1168-76. PubMed ID: 17071635
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of caspofungin against Aspergillus terreus.
Barchiesi F; Spreghini E; Santinelli A; Fothergill AW; Fallani S; Manso E; Pisa E; Giannini D; Novelli A; Cassetta MI; Mazzei T; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Dec; 49(12):5133-5. PubMed ID: 16304185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
